InvestorsHub Logo
Followers 54
Posts 2839
Boards Moderated 0
Alias Born 03/17/2014

Re: OTCShotCaller post# 31695

Sunday, 10/11/2020 9:52:48 AM

Sunday, October 11, 2020 9:52:48 AM

Post# of 198774
Great post. 136 made the connection with Johnson and Johnson as Mr. Charles Cotropia informed on his
“Our Anti-HIV Monoclonal Antibody Progress” October 7th 2018 as follows:

In a conversation this week with Johnson & Johnson, a company focused on HIV therapy, our technology was well received and recognized as being significant and the data persuasive. However, Johnson and Johnson indicated that it would need to see results in animal trials before it would be in a position to buy-in to the technology.



https://www.linkedin.com/pulse/our-anti-hiv-monoclonal-antibody-progress-charles-s-cotropia?articleId=6454774694473187328#comments-6454774694473187328&trk=public_profile_article_view

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158823523

$ENZC

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News